Fig. 2From: Prognostic value of MRI volumetric parameters in non-small cell lung cancer patients after immune checkpoint inhibitor therapy: comparison with response assessment criteriaComparison of mRECIST, RANO-BM, and iRANO-BM CriteriamRECIST: modified Response Evaluation Criteria in Solid Tumors; RANO-BM: Response Assessment in Neuro-Oncology Brain Metastases; iRANO-BM: immunotherapy Response Assessment in Neuro-Oncology adjusted for Brain MetastasesBack to article page